Today: 11 June 2026
LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020
31 December 2025
1 min read

LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020

NEW YORK, Dec 31, 2025, 12:13 ET — Regular session

  • LandBridge shares fell about 3% and briefly touched a new 52-week low.
  • Oil prices were on track for a steep annual drop, keeping pressure on energy-linked names.
  • Traders are watching early-January OPEC+ headlines and the next LandBridge earnings update window.

LandBridge Company LLC shares slid on Wednesday and briefly set a new 52-week low, extending a late-year pullback as investors weighed a weaker crude backdrop and a risk-off tone in energy-linked pockets of the market.

The stock was down 3.2% at $48.63 in midday trading, after touching an intraday low of $48.29 — below the prior 52-week floor flagged in market reports.

The move matters now because LandBridge’s business is tied to activity in the Permian Basin through surface and related revenue streams, leaving sentiment sensitive to the direction of oil prices and drilling economics — especially into year-end positioning and early-2026 supply expectations.

Crude was little changed on the day, but markets were focused on the bigger picture: oil was on track for a double-digit annual decline amid oversupply concerns and softer demand growth expectations, Reuters reported.

BNP Paribas commodities analyst Jason Ying said U.S. shale supply could stay “more consistent and insensitive to price movements” because producers were able to hedge at higher levels, a dynamic that can keep a lid on prices and ripple through energy-adjacent equities. Reuters

U.S. inventory data also fed the tape. The EIA reported a bigger-than-expected draw in crude stocks last week, while gasoline and distillate inventories rose sharply on strong refining, Reuters reported.

“Year end numbers tend to be distorted,” said Josh Young, chief investment officer for Bisons Interests, pointing to tax-driven inventory shifts that can blur the signal in late-December data. Reuters

For LandBridge, the slide pushed the shares toward the bottom of their recent trading band. The stock’s 52-week range has run up to $87.60, according to MarketWatch, underscoring how far sentiment has cooled from mid-year highs.

There was no fresh company earnings release on Wednesday; the latest reported quarterly update was the company’s third-quarter results in November, when LandBridge reaffirmed the midpoint of its 2025 adjusted EBITDA outlook range.

With the shares probing new lows, investors will be watching whether buyers defend the high-$40s area, while also tracking volume for signs of capitulation or bargain-hunting after the year-end reset.

Macro catalysts are close on the calendar. OPEC+ is scheduled to meet on Jan. 4, a key near-term checkpoint for supply guidance that can swing crude and energy-linked equities.

On the company calendar, the next earnings window is expected in March for fourth-quarter and full-year updates, based on published event schedules from market data providers.

Peers in the broader oil-and-gas and royalty-linked universe were also in focus as investors repriced 2026 supply/demand risk, with crude’s 2025 slide sharpening sensitivity to any sign that prices could drift into the low-$50s.

Stock Market Today

  • Top Software Stocks Set for Rally in Second Half, Says BofA
    June 11, 2026, 11:15 AM EDT. Bank of America (BofA) has identified leading software stocks poised for a significant rally in the second half of the year. While specific companies were not detailed, BofA's outlook highlights growth potential in the tech sector amid evolving market conditions. Investors are closely watching software firms as demand for digital solutions continues to expand, driven by cloud computing and enterprise software trends. This bullish stance from a major financial institution underscores confidence in software stocks as key components of portfolio growth strategies moving forward.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking
Previous Story

Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Next Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Go toTop